Home » Topics » Disease categories and therapies » Immune

Immune
RSS

ER-49890 prolongs graft survival in murine transplantation models

Sep. 28, 1999

NCI to lead phase II trial of Repligen's CTLA4-Ig

Sep. 28, 1999

New interferon inducers described by Sumitomo and Japan Energy

Sep. 27, 1999

Cantab reports positive phase I results for DISC HSV vaccine

Sep. 24, 1999

Cytokine production modulators identified as part of Japanese pharmaceutical collaboration

Sep. 23, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Newly discovered metabolite of sinomenine with more potent immunosuppressive activity

Sep. 17, 1999

Seragen sublicenses daclizumab patents to Roche

Sep. 16, 1999

Interleukin Genetics applies for inflammatory gene patent

Sep. 15, 1999

Chiron seeks U.K. approval for meningitis vaccine

Sep. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.